Showing results (91-100 of 153) with videos related to
Sort By:
Pageof 16
Translational Cancer Research|April 15, 2024
A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancerPeng Zhang, Jingjing Yang, Xiaolong Zhong, et al.Biomed Research International|January 11, 2018
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 BlockadeMichele Moschetta, Mario Uccello, Benjamin Kasenda, et al.Current Cancer Drug Targets|February 9, 2023
Advances in Ovarian Cancer Treatment Beyond PARP InhibitorsFine Aliyuda, Michele Moschetta, Aruni Ghose, et al.Toxicology Reports|September 25, 2024
An overview of immune checkpoint inhibitor toxicities in bladder cancerAvenie Mavadia, Sunyoung Choi, Ayden Ismail, et al.Drugs in R&D|March 28, 2020
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and BeyondStergios Boussios, Charlotte Abson, Michele Moschetta, et al.Cancers|August 26, 2022
BRCA Mutations in Ovarian and Prostate Cancer: Bench to BedsideStergios Boussios, Elie Rassy, Michele Moschetta, et al.Therapeutic Advances in Medical Oncology|December 8, 2025
Therapeutic opportunities in EBV-positive gastric cancer subtypesHasan Al-Sattar, Richard Owen, Amir Mashia Jaafari, et al.Diseases (Basel, Switzerland)|December 22, 2022
Efficacy and Safety of COVID-19 Vaccines-An UpdateEshani Sharma, Sraddha Revinipati, Saisha Bhandari, et al.Medicina (Kaunas, Lithuania)|March 27, 2025
Enhancing Ophthalmic Diagnosis and Treatment with Artificial IntelligenceDavid B Olawade, Kusal Weerasinghe, Mathugamage Don Dasun Eranga Mathugamage, et al.Annals of Palliative Medicine|July 11, 2023
Melanoma-the therapeutic considerations in the clinical practiceSola Adeleke, Somto Okoli, Anojan Augustine, et al.Pageof 16